These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 5466919)
1. Extemporaneous formulation of corticosteroids for topical usage. Burdick KH; Poulsen B; Place VA JAMA; 1970 Jan; 211(3):462-6. PubMed ID: 5466919 [No Abstract] [Full Text] [Related]
2. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test. Coldman MF; Lockerbie L; Laws EA Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552 [No Abstract] [Full Text] [Related]
3. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels. Barry BW; Woodford R Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447 [No Abstract] [Full Text] [Related]
4. [Remarks on the percutaneous absorption of corticoids]. Rimbaud P; Meynadier J Ann Dermatol Syphiligr (Paris); 1968; 95(3):263-7. PubMed ID: 5697207 [No Abstract] [Full Text] [Related]
5. [Skin vasoconstriction assay in the evaluation of topical corticosteroids in man. General problems and results obtained in a series of tests (author's transl)]. Weirich EG; Lutz U Dermatologica; 1973; 147(6):353-75. PubMed ID: 4788215 [No Abstract] [Full Text] [Related]
6. Evaluation of the efficacy of topical corticosteroids. Zaynoun ST; Kurban AK Br J Dermatol; 1974 Jan; 90(1):85-90. PubMed ID: 4811838 [No Abstract] [Full Text] [Related]
7. Extemporaneous formulation of topical corticosteroids. Caldwell HC JAMA; 1970 Jun; 212(11):1963. PubMed ID: 5467695 [No Abstract] [Full Text] [Related]
8. Design of the optimal topical system for fluocinonide. Reinstein J; Ostrenga J; Haleblian J; Shastri S; Poulsen B; Katz M Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):Suppl 67:13-8. PubMed ID: 5291642 [No Abstract] [Full Text] [Related]
9. Inhibition of contact sensitivity in the mouse by topical application of corticosteroids. Evans DP; Hossack M; Thomson DS Br J Pharmacol; 1971 Oct; 43(2):403-8. PubMed ID: 5158205 [TBL] [Abstract][Full Text] [Related]
10. [THE TOPICAL USE OF CORTICOSTEROIDS IN DERMATOLOGY]. POLANO MK Ned Tijdschr Geneeskd; 1965 Jan; 109():180-5. PubMed ID: 14301860 [No Abstract] [Full Text] [Related]
11. Topical corticosteroids--an experimental evaluation of the vasoconstrictor test as an index of anti-inflammatory activity. Reid J; Brookes DB Br J Dermatol; 1968 May; 80(5):328-36. PubMed ID: 4873078 [No Abstract] [Full Text] [Related]
13. Objective measurement of topically applied corticosteroids. Király K; Soós G Dermatologica; 1976; 152 Suppl 1():133-7. PubMed ID: 955233 [TBL] [Abstract][Full Text] [Related]
14. [Comparative studies on the vasoconstrictor effect of various corticosteroids]. Bickhardt R Hautarzt; 1972 Jul; 23(7):301-5. PubMed ID: 4655109 [No Abstract] [Full Text] [Related]
15. The effect of corticosteroids on human epidermal mitotic activity. Fisher LB; Maibach HI Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801 [No Abstract] [Full Text] [Related]